This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Monroe Township, NJ (US) (2014)
- Monroe, NJ (US) (2017)
Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Steven P. Miller
Introduction
Steven P. Miller is an accomplished inventor based in Monroe, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex compounds. With a total of 2 patents, his work has implications in pharmaceutical applications.
Latest Patents
Miller's latest patents include a process for the preparation of chiral tert-butyl 4-((1R,2S,5R)-6(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carb derivatives. This innovative process involves contacting a lactone with an azacycloalkylamine, followed by interaction with a sulfonyl halide in the presence of a tertiary amine base. Additionally, he has developed processes for the enantio- and stereo-specific synthesis of β-amino-α-hydroxy amides, which are useful for preparing intermediates for various compounds.
Career Highlights
Steven P. Miller is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in medicinal chemistry. His expertise in synthesizing complex molecules has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Miller has collaborated with notable colleagues, including John Limanto and Yong-Li Zhong. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Steven P. Miller's contributions to the field of chemistry through his patents and collaborative efforts highlight his role as a significant inventor. His work continues to influence the development of new pharmaceutical compounds and processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
